OTC Pharmaceuticals Global Industry Almanac_2016

Date: October 21, 2016
Pages: 491
Price:
US$ 2,995.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O0105B0208DEN
Leaflet:

Download PDF Leaflet

SUMMARY

Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global otc pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global otc pharmaceuticals market
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global otc pharmaceuticals market with five year forecasts by both value and volume
-

SYNOPSIS

Essential resource for top-line data and analysis covering the global otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

REASONS TO BUY
  • What was the size of the global otc pharmaceuticals market by value in 2015?
  • What will be the size of the global otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the global otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global otc pharmaceuticals market?
KEY HIGHLIGHTS
  • The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.
  • The global OTC pharmaceuticals market generated total revenues of $130,434.6m in 2015, representing a CARC of -1.0% between 2011 and 2015.
  • Traditional medicines registered the highest sales value in the global OTC pharmaceuticals market in 2015, with total sales of $23,987.7m, equivalent to 18.4% of the market's overall value.
  • The largest regional market globally is Asia-Pacific, although the US remains the largest individual country at 29.7% of the market in 2015.
EXECUTIVE SUMMARY

Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global OTC Pharmaceuticals
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Indonesia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in North America
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Scandinavia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Singapore
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in South Korea
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Turkey
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

LIST OF TABLES

Table 1: Global OTC pharmaceuticals market value: $ million, 2011-15
Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Global OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Global OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Global OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011-15
Table 8: Asia-Pacific OTC pharmaceuticals market category segmentation: $ million, 2015
Table 9: Asia-Pacific OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 10: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Table 11: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Table 12: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 13: Europe OTC pharmaceuticals market value: $ million, 2011-15
Table 14: Europe OTC pharmaceuticals market category segmentation: $ million, 2015
Table 15: Europe OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 16: Europe OTC pharmaceuticals market share: % share, by value, 2015
Table 17: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
Table 18: Europe OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 19: France OTC pharmaceuticals market value: $ million, 2011-15
Table 20: France OTC pharmaceuticals market category segmentation: $ million, 2015
Table 21: France OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 22: France OTC pharmaceuticals market share: % share, by value, 2015
Table 23: France OTC pharmaceuticals market distribution: % share, by value, 2015
Table 24: France OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 25: France size of population (million), 2011-15
Table 26: France gdp (constant 2005 prices, $ billion), 2011-15
Table 27: France gdp (current prices, $ billion), 2011-15
Table 28: France inflation, 2011-15
Table 29: France consumer price index (absolute), 2011-15
Table 30: France exchange rate, 2011-15
Table 31: Germany OTC pharmaceuticals market value: $ million, 2011-15
Table 32: Germany OTC pharmaceuticals market category segmentation: $ million, 2015
Table 33: Germany OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 34: Germany OTC pharmaceuticals market share: % share, by value, 2015
Table 35: Germany OTC pharmaceuticals market distribution: % share, by value, 2015
Table 36: Germany OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 37: Germany size of population (million), 2011-15
Table 38: Germany gdp (constant 2005 prices, $ billion), 2011-15
Table 39: Germany gdp (current prices, $ billion), 2011-15
Table 40: Germany inflation, 2011-15
Table 41: Germany consumer price index (absolute), 2011-15
Table 42: Germany exchange rate, 2011-15
Table 43: Australia OTC pharmaceuticals market value: $ million, 2011-15
Table 44: Australia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 45: Australia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 46: Australia OTC pharmaceuticals market share: % share, by value, 2015
Table 47: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 48: Australia OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 49: Australia size of population (million), 2011-15
Table 50: Australia gdp (constant 2005 prices, $ billion), 2011-15
Table 51: Australia gdp (current prices, $ billion), 2011-15
Table 52: Australia inflation, 2011-15
Table 53: Australia consumer price index (absolute), 2011-15
Table 54: Australia exchange rate, 2011-15
Table 55: Brazil OTC pharmaceuticals market value: $ million, 2011-15
Table 56: Brazil OTC pharmaceuticals market category segmentation: $ million, 2015
Table 57: Brazil OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 58: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Table 59: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Table 60: Brazil OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 61: Brazil size of population (million), 2011-15
Table 62: Brazil gdp (constant 2005 prices, $ billion), 2011-15
Table 63: Brazil gdp (current prices, $ billion), 2011-15
Table 64: Brazil inflation, 2011-15
Table 65: Brazil consumer price index (absolute), 2011-15
Table 66: Brazil exchange rate, 2011-15
Table 67: Canada OTC pharmaceuticals market value: $ million, 2011-15
Table 68: Canada OTC pharmaceuticals market category segmentation: $ million, 2015
Table 69: Canada OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 70: Canada OTC pharmaceuticals market share: % share, by value, 2015
Table 71: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
Table 72: Canada OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 73: Canada size of population (million), 2011-15
Table 74: Canada gdp (constant 2005 prices, $ billion), 2011-15
Table 75: Canada gdp (current prices, $ billion), 2011-15
Table 76: Canada inflation, 2011-15
Table 77: Canada consumer price index (absolute), 2011-15
Table 78: Canada exchange rate, 2011-15
Table 79: China OTC pharmaceuticals market value: $ million, 2011-15
Table 80: China OTC pharmaceuticals market category segmentation: $ million, 2015
Table 81: China OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 82: China OTC pharmaceuticals market share: % share, by value, 2015
Table 83: China OTC pharmaceuticals market distribution: % share, by value, 2015
Table 84: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 85: China size of population (million), 2011-15
Table 86: China gdp (constant 2005 prices, $ billion), 2011-15
Table 87: China gdp (current prices, $ billion), 2011-15
Table 88: China inflation, 2011-15
Table 89: China consumer price index (absolute), 2011-15
Table 90: China exchange rate, 2011-15
Table 91: India OTC pharmaceuticals market value: $ million, 2011-15
Table 92: India OTC pharmaceuticals market category segmentation: $ million, 2015
Table 93: India OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 94: India OTC pharmaceuticals market share: % share, by value, 2015
Table 95: India OTC pharmaceuticals market distribution: % share, by value, 2015
Table 96: India OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 97: India size of population (million), 2011-15
Table 98: India gdp (constant 2005 prices, $ billion), 2011-15
Table 99: India gdp (current prices, $ billion), 2011-15
Table 100: India inflation, 2011-15
Table 101: India consumer price index (absolute), 2011-15
Table 102: India exchange rate, 2011-15
Table 103: Indonesia OTC pharmaceuticals market value: $ million, 2011-15
Table 104: Indonesia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 105: Indonesia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 106: Indonesia OTC pharmaceuticals market share: % share, by value, 2015
Table 107: Indonesia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 108: Indonesia OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 109: Indonesia size of population (million), 2011-15
Table 110: Indonesia gdp (constant 2005 prices, $ billion), 2011-15
Table 111: Indonesia gdp (current prices, $ billion), 2011-15
Table 112: Indonesia inflation, 2011-15
Table 113: Indonesia consumer price index (absolute), 2011-15
Table 114: Indonesia exchange rate, 2011-15
Table 115: Italy OTC pharmaceuticals market value: $ million, 2011-15
Table 116: Italy OTC pharmaceuticals market category segmentation: $ million, 2015
Table 117: Italy OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 118: Italy OTC pharmaceuticals market share: % share, by value, 2015
Table 119: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
Table 120: Italy OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 121: Italy size of population (million), 2011-15
Table 122: Italy gdp (constant 2005 prices, $ billion), 2011-15
Table 123: Italy gdp (current prices, $ billion), 2011-15
Table 124: Italy inflation, 2011-15
Table 125: Italy consumer price index (absolute), 2011-15
Table 126: Italy exchange rate, 2011-15
Table 127: Japan OTC pharmaceuticals market value: $ million, 2011-15
Table 128: Japan OTC pharmaceuticals market category segmentation: $ million, 2015
Table 129: Japan OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 130: Japan OTC pharmaceuticals market share: % share, by value, 2015
Table 131: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
Table 132: Japan OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 133: Japan size of population (million), 2011-15
Table 134: Japan gdp (constant 2005 prices, $ billion), 2011-15
Table 135: Japan gdp (current prices, $ billion), 2011-15
Table 136: Japan inflation, 2011-15
Table 137: Japan consumer price index (absolute), 2011-15
Table 138: Japan exchange rate, 2011-15
Table 139: Mexico OTC pharmaceuticals market value: $ million, 2011-15
Table 140: Mexico OTC pharmaceuticals market category segmentation: $ million, 2015
Table 141: Mexico OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 142: Mexico OTC pharmaceuticals market share: % share, by value, 2015
Table 143: Mexico OTC pharmaceuticals market distribution: % share, by value, 2015
Table 144: Mexico OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 145: Mexico size of population (million), 2011-15
Table 146: Mexico gdp (constant 2005 prices, $ billion), 2011-15
Table 147: Mexico gdp (current prices, $ billion), 2011-15
Table 148: Mexico inflation, 2011-15
Table 149: Mexico consumer price index (absolute), 2011-15
Table 150: Mexico exchange rate, 2011-15
Table 151: Netherlands OTC pharmaceuticals market value: $ million, 2011-15
Table 152: Netherlands OTC pharmaceuticals market category segmentation: $ million, 2015
Table 153: Netherlands OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 154: Netherlands OTC pharmaceuticals market share: % share, by value, 2015
Table 155: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015
Table 156: Netherlands OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 157: Netherlands size of population (million), 2011-15
Table 158: Netherlands gdp (constant 2005 prices, $ billion), 2011-15
Table 159: Netherlands gdp (current prices, $ billion), 2011-15
Table 160: Netherlands inflation, 2011-15
Table 161: Netherlands consumer price index (absolute), 2011-15
Table 162: Netherlands exchange rate, 2011-15
Table 163: North America OTC pharmaceuticals market value: $ million, 2011-15
Table 164: North America OTC pharmaceuticals market category segmentation: $ million, 2015
Table 165: North America OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 166: North America OTC pharmaceuticals market share: % share, by value, 2015
Table 167: North America OTC pharmaceuticals market distribution: % share, by value, 2015
Table 168: North America OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 169: Russia OTC pharmaceuticals market value: $ million, 2011-15
Table 170: Russia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 171: Russia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 172: Russia OTC pharmaceuticals market share: % share, by value, 2015
Table 173: Russia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 174: Russia OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 175: Russia size of population (million), 2011-15
Table 176: Russia gdp (constant 2005 prices, $ billion), 2011-15
Table 177: Russia gdp (current prices, $ billion), 2011-15
Table 178: Russia inflation, 2011-15
Table 179: Russia consumer price index (absolute), 2011-15
Table 180: Russia exchange rate, 2011-15
Table 181: Scandinavia OTC pharmaceuticals market value: $ million, 2011-15
Table 182: Scandinavia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 183: Scandinavia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 184: Scandinavia OTC pharmaceuticals market share: % share, by value, 2015
Table 185: Scandinavia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 186: Scandinavia OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 187: Singapore OTC pharmaceuticals market value: $ million, 2011-15
Table 188: Singapore OTC pharmaceuticals market category segmentation: $ million, 2015
Table 189: Singapore OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 190: Singapore OTC pharmaceuticals market share: % share, by value, 2015
Table 191: Singapore OTC pharmaceuticals market distribution: % share, by value, 2015
Table 192: Singapore OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 193: Singapore size of population (million), 2011-15
Table 194: Singapore gdp (constant 2005 prices, $ billion), 2011-15
Table 195: Singapore gdp (current prices, $ billion), 2011-15
Table 196: Singapore inflation, 2011-15
Table 197: Singapore consumer price index (absolute), 2011-15
Table 198: Singapore exchange rate, 2011-15
Table 199: South Africa OTC pharmaceuticals market value: $ million, 2011-15
Table 200: South Africa OTC pharmaceuticals market category segmentation: $ million, 2015
Table 201: South Africa OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 202: South Africa OTC pharmaceuticals market share: % share, by value, 2015
Table 203: South Africa OTC pharmaceuticals market distribution: % share, by value, 2015
Table 204: South Africa OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 205: South Africa size of population (million), 2011-15
Table 206: South Africa gdp (constant 2005 prices, $ billion), 2011-15
Table 207: South Africa gdp (current prices, $ billion), 2011-15
Table 208: South Africa inflation, 2011-15
Table 209: South Africa consumer price index (absolute), 2011-15
Table 210: South Africa exchange rate, 2011-15
Table 211: South Korea OTC pharmaceuticals market value: $ million, 2011-15
Table 212: South Korea OTC pharmaceuticals market category segmentation: $ million, 2015
Table 213: South Korea OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 214: South Korea OTC pharmaceuticals market share: % share, by value, 2015
Table 215: South Korea OTC pharmaceuticals market distribution: % share, by value, 2015
Table 216: South Korea OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 217: South Korea size of population (million), 2011-15
Table 218: South Korea gdp (constant 2005 prices, $ billion), 2011-15
Table 219: South Korea gdp (current prices, $ billion), 2011-15
Table 220: South Korea inflation, 2011-15
Table 221: South Korea consumer price index (absolute), 2011-15
Table 222: South Korea exchange rate, 2011-15
Table 223: Spain OTC pharmaceuticals market value: $ million, 2011-15
Table 224: Spain OTC pharmaceuticals market category segmentation: $ million, 2015
Table 225: Spain OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 226: Spain OTC pharmaceuticals market share: % share, by value, 2015
Table 227: Spain OTC pharmaceuticals market distribution: % share, by value, 2015
Table 228: Spain OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 229: Spain size of population (million), 2011-15
Table 230: Spain gdp (constant 2005 prices, $ billion), 2011-15
Table 231: Spain gdp (current prices, $ billion), 2011-15
Table 232: Spain inflation, 2011-15
Table 233: Spain consumer price index (absolute), 2011-15
Table 234: Spain exchange rate, 2011-15
Table 235: Turkey OTC pharmaceuticals market value: $ million, 2011-15
Table 236: Turkey OTC pharmaceuticals market category segmentation: $ million, 2015
Table 237: Turkey OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 238: Turkey OTC pharmaceuticals market share: % share, by value, 2015
Table 239: Turkey OTC pharmaceuticals market distribution: % share, by value, 2015
Table 240: Turkey OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 241: Turkey size of population (million), 2011-15
Table 242: Turkey gdp (constant 2005 prices, $ billion), 2011-15
Table 243: Turkey gdp (current prices, $ billion), 2011-15
Table 244: Turkey inflation, 2011-15
Table 245: Turkey consumer price index (absolute), 2011-15
Table 246: Turkey exchange rate, 2011-15
Table 247: United Kingdom OTC pharmaceuticals market value: $ million, 2011-15
Table 248: United Kingdom OTC pharmaceuticals market category segmentation: $ million, 2015
Table 249: United Kingdom OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 250: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015
Table 251: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015
Table 252: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 253: United Kingdom size of population (million), 2011-15
Table 254: United Kingdom gdp (constant 2005 prices, $ billion), 2011-15
Table 255: United Kingdom gdp (current prices, $ billion), 2011-15
Table 256: United Kingdom inflation, 2011-15
Table 257: United Kingdom consumer price index (absolute), 2011-15
Table 258: United Kingdom exchange rate, 2011-15
Table 259: United States OTC pharmaceuticals market value: $ million, 2011-15
Table 260: United States OTC pharmaceuticals market category segmentation: $ million, 2015
Table 261: United States OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 262: United States OTC pharmaceuticals market share: % share, by value, 2015
Table 263: United States OTC pharmaceuticals market distribution: % share, by value, 2015
Table 264: United States OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 265: United States size of population (million), 2011-15
Table 266: United States gdp (constant 2005 prices, $ billion), 2011-15
Table 267: United States gdp (current prices, $ billion), 2011-15
Table 268: United States inflation, 2011-15
Table 269: United States consumer price index (absolute), 2011-15
Table 270: United States exchange rate, 2011-15
Table 271: Bayer AG: key facts
Table 272: Bayer AG: key financials ($)
Table 273: Bayer AG: key financials (€)
Table 274: Bayer AG: key financial ratios
Table 275: GlaxoSmithKline Plc: key facts
Table 276: GlaxoSmithKline Plc: key financials ($)
Table 277: GlaxoSmithKline Plc: key financials (£)
Table 278: GlaxoSmithKline Plc: key financial ratios
Table 279: Johnson & Johnson: key facts
Table 280: Johnson & Johnson: key financials ($)
Table 281: Johnson & Johnson: key financial ratios
Table 282: Novartis AG: key facts
Table 283: Novartis AG: key financials ($)
Table 284: Novartis AG: key financial ratios
Table 285: Nin Jiom Medicines Manufactory Ltd: key facts
Table 286: The Procter & Gamble Company: key facts
Table 287: The Procter & Gamble Company: key financials ($)
Table 288: The Procter & Gamble Company: key financial ratios
Table 289: Reckitt Benckiser Group plc: key facts
Table 290: Reckitt Benckiser Group plc: key financials ($)
Table 291: Reckitt Benckiser Group plc: key financials (£)
Table 292: Reckitt Benckiser Group plc: key financial ratios
Table 293: Sanofi SA: key facts
Table 294: Sanofi SA: key financials ($)
Table 295: Sanofi SA: key financials (€)
Table 296: Sanofi SA: key financial ratios
Table 297: Almirall S.A.: key facts
Table 298: Almirall S.A.: key financials ($)
Table 299: Almirall S.A.: key financials (€)
Table 300: Almirall S.A.: key financial ratios
Table 301: Pfizer Inc.: key facts
Table 302: Pfizer Inc.: key financials ($)
Table 303: Pfizer Inc.: key financial ratios
Table 304: Suntory Group: key facts
Table 305: Suntory Group: key financials ($)
Table 306: Suntory Group: key financials (¥)
Table 307: Suntory Group: key financial ratios
Table 308: Abbott Laboratories: key facts
Table 309: Abbott Laboratories: key financials ($)
Table 310: Abbott Laboratories: key financial ratios
Table 311: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts
Table 312: Cipla Limited: key facts
Table 313: Cipla Limited: key financials ($)
Table 314: Cipla Limited: key financials (Rs.)
Table 315: Cipla Limited: key financial ratios
Table 316: Dabur India Limited: key facts
Table 317: Dabur India Limited: key financials ($)
Table 318: Dabur India Limited: key financials (Rs.)
Table 319: Dabur India Limited: key financial ratios
Table 320: Darya-Varia Laboratoria Tbk: key facts
Table 321: Darya-Varia Laboratoria Tbk: key financials ($)
Table 322: Darya-Varia Laboratoria Tbk: key financials (IDR)
Table 323: Darya-Varia Laboratoria Tbk: key financial ratios
Table 324: PT Kalbe Farma Tbk: key facts
Table 325: PT Kalbe Farma Tbk: key financials ($)
Table 326: PT Kalbe Farma Tbk: key financials (IDR)
Table 327: PT Kalbe Farma Tbk: key financial ratios
Table 328: Boehringer Ingelheim GmbH: key facts
Table 329: Boehringer Ingelheim GmbH: key financials ($)
Table 330: Boehringer Ingelheim GmbH: key financials (€)
Table 331: Boehringer Ingelheim GmbH: key financial ratios
Table 332: Daiichi Sankyo Co., Ltd.: key facts
Table 333: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 334: Daiichi Sankyo Co., Ltd.: key financials (¥)
Table 335: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 336: Kracie Holdings, Ltd.: key facts
Table 337: Bristol Myers Squibb Company: key facts
Table 338: Bristol Myers Squibb Company: key financials ($)
Table 339: Bristol Myers Squibb Company: key financial ratios
Table 340: Royal DSM N.V.: key facts
Table 341: Royal DSM N.V.: key financials ($)
Table 342: Royal DSM N.V.: key financials (€)
Table 343: Royal DSM N.V.: key financial ratios
Table 344: JSC ELFA: key facts
Table 345: The Menarini Group: key facts
Table 346: The Menarini Group: key financials ($)
Table 347: The Menarini Group: key financials (€)
Table 348: The Menarini Group: key financial ratios
Table 349: Pharmstandard OJSC: key facts
Table 350: Pharmstandard OJSC: key financials ($)
Table 351: Pharmstandard OJSC: key financials (RUB)
Table 352: Pharmstandard OJSC: key financial ratios
Table 353: Eu Yan Sang International Ltd.: key facts
Table 354: Eu Yan Sang International Ltd.: key financials ($)
Table 355: Eu Yan Sang International Ltd.: key financials (Si$)
Table 356: Eu Yan Sang International Ltd.: key financial ratios
Table 357: Adcock Ingram Holdings Limited: key facts
Table 358: Adcock Ingram Holdings Limited: key financials ($)
Table 359: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 360: Adcock Ingram Holdings Limited: key financial ratios
Table 361: Pharma Natura (Pty) Ltd.: key facts
Table 362: Weleda AG: key facts
Table 363: Boryung Pharm Co., Ltd.: key facts
Table 364: Boryung Pharm Co., Ltd.: key financials ($)
Table 365: Boryung Pharm Co., Ltd.: key financials (KRW)
Table 366: Boryung Pharm Co., Ltd.: key financial ratios
Table 367: Dongwha Pharm Co., Ltd.: key facts
Table 368: Whanin Pharmaceutical Co., Ltd.: key facts
Table 369: Whanin Pharmaceutical Co., Ltd.: key financials ($)
Table 370: Whanin Pharmaceutical Co., Ltd.: key financials (KRW)
Table 371: Whanin Pharmaceutical Co., Ltd.: key financial ratios
Table 372: Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.: key facts
Table 373: Nobel Ilac San ve Tic A.S.: key facts

LIST OF FIGURES

Figure 1: Global OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Global OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Global OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Global OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the global OTC pharmaceuticals market, 2015
Figure 8: Drivers of buyer power in the global OTC pharmaceuticals market, 2015
Figure 9: Drivers of supplier power in the global OTC pharmaceuticals market, 2015
Figure 10: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2015
Figure 11: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2015
Figure 12: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2015
Figure 13: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011-15
Figure 14: Asia-Pacific OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 15: Asia-Pacific OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 16: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Figure 17: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 18: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 19: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 20: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 21: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 22: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 23: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 24: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 25: Europe OTC pharmaceuticals market value: $ million, 2011-15
Figure 26: Europe OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 27: Europe OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 28: Europe OTC pharmaceuticals market share: % share, by value, 2015
Figure 29: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 30: Europe OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 31: Forces driving competition in the OTC pharmaceuticals market in Europe, 2015
Figure 32: Drivers of buyer power in the OTC pharmaceuticals market in Europe, 2015
Figure 33: Drivers of supplier power in the OTC pharmaceuticals market in Europe, 2015
Figure 34: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Europe, 2015
Figure 35: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Europe, 2015
Figure 36: Drivers of degree of rivalry in the OTC pharmaceuticals market in Europe, 2015
Figure 37: France OTC pharmaceuticals market value: $ million, 2011-15
Figure 38: France OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 39: France OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 40: France OTC pharmaceuticals market share: % share, by value, 2015
Figure 41: France OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 42: France OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 43: Forces driving competition in the OTC pharmaceuticals market in France, 2015
Figure 44: Drivers of buyer power in the OTC pharmaceuticals market in France, 2015
Figure 45: Drivers of supplier power in the OTC pharmaceuticals market in France, 2015
Figure 46: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in France, 2015
Figure 47: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in France, 2015
Figure 48: Drivers of degree of rivalry in the OTC pharmaceuticals market in France, 2015
Figure 49: Germany OTC pharmaceuticals market value: $ million, 2011-15
Figure 50: Germany OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 51: Germany OTC pharmaceuticals market g
Skip to top


World OTC Pharmaceutical Market 2012-2022 US$ 2,635.00 Jun, 2012 · 147 pages
OTC Pharmaceuticals in Asia-Pacific US$ 350.00 Sep, 2016 · 36 pages

Ask Your Question

OTC Pharmaceuticals Global Industry Almanac_2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: